Genesis Therapeutics lands $200m Series B
The investors include returning backer Andreessen Horowitz, which led the company's seed round.
The investors include returning backer Andreessen Horowitz, which led the company's seed round.
Copyright PEI Media
Not for publication, email or dissemination
